The definition, presentation, and management of myocardial infarction (MI) have changed substantially in the last decade. Whether these changes have impacted on the presence, severity, and localization of necrosis at myocardial perfusion imaging (MPI) has not been appraised to date. Subjects undergoing MPI and reporting a history of clinical MI were shortlisted. We focused on the presence, severity, and localization of necrosis at MPI with a retrospective single-center analysis. A total of 10,476 patients were included, distinguishing 5 groups according to the period in which myocardial perfusion scintigraphy had been performed ( Trend analysis showed over time a significant worsening in baseline features (e.g., age, diabetes mellitus, and Q waves at electrocardiogram), whereas medical therapy and revascularization were offered with increasing frequency. Over the years, there was also a lower prevalence of normal MPI (from 16.8% to 13.6%) and ischemic MPI (from 35.6% to 32.8%), and a higher prevalence of ischemic and necrotic MPI (from 12.0% to 12.7%) or solely necrotic MPI (from 35.7% to 40.9%, p <0.001). Yet the prevalence of severe ischemia decreased over time from 11.4% to 2.0%, with a similar trend for moderate ischemia (from 15.9% to 11.8%, p <0.001). Similarly sobering results were wound for the prevalence of severe necrosis (from 19.8% to 8.2%) and moderate necrosis (from 8.5% to 7.8%, p = 0.028). These trends were largely confirmed at regional level and after propensity score matching. In conclusion, the outlook of stable patients with previous MI has substantially improved in the last decade, with a decrease in the severity of residual myocardial ischemia and necrosis, despite an apparent worsening in baseline features. © 2017 Elsevier Inc. All rights reserved. (Am J Cardiol 2017;120:1238-1244)
The main characterizations of myocardial infarction (MI) are based on Q waves and ST segment changes at electrocardiogram, [1] [2] [3] thus distinguishing Q-wave versus non-Q-wave MI and ST elevation MI (STEMI) versus non-ST elevation MI (NSTEMI) [2] [3] [4] [5] . Improvements in MI prevention and treatment have reduced its incidence, lead to fewer STEMI, and globally improved its prognosis. Yet an aging population with frequent co-morbidities implies that MI will remain a common condition. Temporal trends in MI are well established, but there are no precise data on temporal changes of myocardial ischemia or necrosis after MI. This is at odds with details on myocardial ischemia in naïve patients 6 . Awareness of trends in myocardial ischemia and necrosis in stable patients after MI would prove important to appraise the impact of current management strategies and plan treatment and rehabilitation.
Methods
This is a sub-analysis of an ongoing retrospective study based on our administrative myocardial perfusion imaging (MPI) database, whose details have been already provided elsewhere 6, 7 . Patients provided written informed consent for data collection and analysis, and the main retrospective study was approved by the competent review board.
Patients undergoing MPI since 2004 for the diagnostic or prognostic work-up of coronary artery disease and reporting MI (defined as the presence of clinical symptoms or signs of myocardial ischemia, associated with increased cardiac biomarkers, pathologic Q waves at the electrocardiogram, akinesis or dyskinesis at left ventricle imaging studies) occurring 6 months or more before MPI were identified, excluding those aged <18 years. Stress testing was based on bicycle stress or dipyridamole. 201 Thallium (IBA Molecular Italy, Monza, Italy) a was used for peak and rest single-photon emission computed tomography. A dual-head gamma camera (Millennium MG or Millennium MyoSIGHT, GE Healthcare, Milan, Italy) was used for imaging.
Semiquantitative interpretation of stress or rest images was performed based on a 7-region model, finally obtaining for each region a 5-point scoring system (from 0 [normal uptake] to 4 [severely reduced or absent uptake]). This score directly yielded 5 classes of maximal ischemia score, with the final maximal ischemia score strictly depending on the worst region of perfusion. Similarly, a maximal necrosis score was computed, distinguishing 5 classes (from 0 [no necrosis] to 4 [severe necrosis]). Gated single-photon emission computed tomography was used to appraise regional contractility distinguishing 4 separate classes (0-normokinesis; 1-hypokinesis; 2-akinesis; 3-dyskinesis) 7 revascularizations, less surgical revascularizations, and comprehensive improvements in medical therapy. Temporal changes in baseline features were mirrored by temporal differences in stress features ( Table 2) .
Analysis of temporal trends in MPI showed over the years a lower prevalence of normal MPI (from 16.8% to 13.6%) and ischemic MPI (from 35.6% to 32.8%), and a higher prevalence of ischemic and necrotic MPI (from 12.0% to 12.7%) or solely necrotic MPI (from 35.7% to 40.9%, p <0.001) (Figure 1) . Notably, the prevalence of severe ischemia decreased over time from 11.4% to 2.0%, with a similar trend for moderate ischemia (from 15.9% to 11.8%) (Figure 2 ). Similarly, favorable results for changes in the prevalence of severe necrosis (from 19.8% to 8.2%) and moderate necrosis (from 8.5% to 7.8%, p = 0.028) (Figure 3) .
Moving from the patient to the regional level of analysis (Table 3) showed a progressive increase in the prevalence of apical, inferior, posterior, and lateral ischemia (all p <0.05). Necrosis was more common over the years in the anterior proximal-mid, septal, inferior, and posterior regions (all p <0.001). Finally, regional akinesis or dyskinesis appeared less common over time in the apical regions, but more common in the septal and lateral regions (all p <0.05).
Discussion
Coronary artery disease continues to carry a substantial morbidity and mortality burden 1 . Acutely, the risk of arrhythmias or mechanical complications remains important, whereas, chronically, the adverse effect on myocardial function continues to impact even on stable patients. Yet there have been dramatic changes in the way MI presents and is approached over the years [2] [3] [4] . Physicians have modified substantially their definitions and classifications, moving progressively toward more sensitive albeit potentially less specific ones 4 . Incidence rates have also changed substantially, and overall age-and sex-adjusted rates have declined, with an accompanying shift toward more NSTEMI than STEMI 5 . In addition, short-and long-term prognoses of MI have significantly improved. Several factors play a role, on top of population trends and patient features, including prevention, treatment, and rehabilitation strategies. For instance, mechanical reperfusion of STEMI and invasive management for NSTEMI have become commonplace. Indeed, this is well shown locally, as our center serves a large catchment area in the Lazio region in Italy. Corresponding figures for the uptake of primary or rescue percutaneous coronary intervention (PCI) or any PCI for our period of interest highlight that in our region of more than 5 million inhabitants, there were 1,428 primary or rescue PCI and 8,428 any PCI in 2004, in comparison with as many as 2,648 and 11,002, respectively, in 2013. 9 Adjusting for changes in the population size, this amounts to a ratio of primary or rescue PCI per 10,000 inhabitants*year of 2.7 in 2004 and 4.5 in 2013, whereas the ratio for any PCI went from 16.0 to 18.7. Although the successes of our fight against MI are many, we continue to face the growing epidemic of patients with heart failure, who feature, at least in part, some of the very acute MI patients we have saved from death in the first place but who will end up developing chronic complications of MI. Temporal trends in stable naïve patients undergoing MPI have already been analyzed in detail, highlighting an increase in the prevalence of normal scans and an overall improvement in the ischemic outlook 6, 10, 11 . Yet there are no studies to date focusing specifically on temporal trends in myocardial ischemia and necrosis (or viability) in stable patients with clinical MI. The present study aimed indeed to address this issue. We found that, despite a worsening baseline profile and an increase in the prevalence of abnormal scans, the severity of myocardial necrosis and myocardial ischemia improved over time, in keeping with similar favorable trends on left ventricle dimension and systolic function. These results confirm that our ongoing preventive, therapeutic, and rehabilitative efforts appear to have, at least in part, succeeded in improving the outlook of patients with MI as far as ischemic and necrotic burden are concerned. Yet several unmet needs remain, and it should be borne in mind that even minor areas of necrosis may still impact detrimentally on patient symptoms, signs, or prognosis (e.g., by promoting arrhythmias or unfavorable remodeling).
This work has several limitations, including the retrospective design, the single-center setting, and the use of administrative data. In addition, we relied on clinical history and patient documents to define a clinical MI, and thus we cannot exclude the impact of information bias, on top of selection and referral bias. Another limitation is the lack of ancillary testing modalities, including fractional flow reserve (invasive or noninvasive) and coronary flow reserve (invasive or noninvasive), which could have proven important for both diagnostic and prognostic characterization of the patients 12 .
Finally, complete revascularization during or after MI can also impact on subsequent MPI results, but this detailed analysis was beyond the scope of our work 13 .
In conclusion, the outlook of stable patients with previous MI has substantially improved in the last decade, with a decrease in the severity of residual myocardial and necrosis, despite an apparent worsening in baseline features (Tables 4-6 ).
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